The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tung Roger D since 2014.
This trader's CIK number is 1594857.
At the time of last reporting, Tung Roger D was the Chief Executive Officer of Concert Pharmaceuticals, Inc.. (stock ticker symbol CNCE).
Also see all insider trading activities at Concert Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | CNCE | 0 | $0 | 9,240 | $66,897 | 0 | $0 |
| 2022 | CNCE | 0 | $0 | 22,720 | $70,204 | 0 | $0 |
| 2021 | CNCE | 0 | $0 | 20,180 | $121,310 | 6,700 | $23,450 |
| 2020 | CNCE | 0 | $0 | 0 | $0 | 14,601 | $55,337 |
| 2019 | CNCE | 0 | $0 | 0 | $0 | 52,653 | $223,146 |
| 2018 | CNCE | 0 | $0 | 0 | $0 | 27,757 | $127,127 |
| 2017 | CNCE | 0 | $0 | 0 | $0 | 7,340 | $33,617 |
| 2016 | CNCE | 19,610 | $206,885 | 0 | $0 | 18,000 | $82,440 |
| 2015 | CNCE | 0 | $0 | 0 | $0 | 28,495 | $32,199 |
| 2014 | CNCE | 0 | $0 | 0 | $0 | 60,000 | $67,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-06 | CNCE | Sale | 9,240 | 7.24 | 66,897 |
| 2022-02-15 | CNCE | Sale | 13,480 | 3.09 | 41,653 |
| 2022-01-06 | CNCE | Sale | 9,240 | 3.09 | 28,551 |
| 2021-12-13 | CNCE | Option Ex | 6,700 | 3.50 | 23,450 |
| 2021-12-13 | CNCE | Sale | 6,700 | 3.62 | 24,254 |
| 2021-02-17 | CNCE | Sale | 13,480 | 7.20 | 97,056 |
| 2020-03-13 | CNCE | Option Ex | 14,601 | 3.79 | 55,337 |
| 2019-12-04 | CNCE | Option Ex | 13,166 | 4.41 | 58,062 |
| 2019-04-23 | CNCE | Option Ex | 14,601 | 3.79 | 55,337 |
| 2019-04-10 | CNCE | Option Ex | 24,886 | 4.41 | 109,747 |
| 2018-03-02 | CNCE | Option Ex | 27,757 | 4.58 | 127,127 |
| 2017-11-17 | CNCE | Option Ex | 7,340 | 4.58 | 33,617 |
| 2016-05-11 | CNCE | Buy | 19,610 | 10.55 | 206,885 |
| 2016-01-11 | CNCE | Option Ex | 18,000 | 4.58 | 82,440 |
| 2015-02-17 | CNCE | Option Ex | 28,495 | 1.13 | 32,199 |
| 2014-05-22 | CNCE | Option Ex | 60,000 | 1.13 | 67,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tung Roger D (Chief Executive Officer of Concert Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.